Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3220  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (94 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References

 Article Access Statistics
    PDF Downloaded218    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 2005  |  Volume : 51  |  Issue : 2  |  Page : 152-153

Insulin prescription errors

Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu - 632004, India

Correspondence Address:
John Mathew
Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu - 632004
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 16006715

Rights and PermissionsRights and Permissions

How to cite this article:
Mathew J, Senthil V K. Insulin prescription errors. J Postgrad Med 2005;51:152-3

How to cite this URL:
Mathew J, Senthil V K. Insulin prescription errors. J Postgrad Med [serial online] 2005 [cited 2023 Jun 4];51:152-3. Available from:


The articles on drug prescription practices in India and the accompanying editorial in the Journal of Postgraduate Medicine were timely. [1],[2],[3] We would like to highlight the medication errors that occur due to faulty practices encountered while prescribing insulin.

In India, there are at least 7 different companies supplying insulin in various forms. Availability of multiple species (bovine, porcine and human), different formulations (regular, NPH, lente, 30/70 and 50/50 combinations) and a variety of insulin analogs and their combinations add to the complexities in prescribing insulin. Errors involved in timing of insulin doses and illegible handwriting (confusing IU or U for 0 etc.) add to the prevalent confusion. For the sake of convenience, several doctors relate to regular insulin as "clear insulin". But in the current scenario, "clear" insulin could mean regular insulin, Lispro, Aspart or Glargine. Further, patients on Lispro (or Aspart) with Glargine combinations will be using two types of clear insulins. Mistaken identity resulting in hypoglycaemia has been reported.[4]

In addition, some physicians prescribe "Insulin L" which could mean either Lente (an intermediate acting insulin) or Lantus (Glargine, a long acting analogue).[5] Another source of confusion is the use of combination-premixed insulin. Patients who remember their insulin as 30/70 may be using either a premixed combination of human insulin (e.g. Huminsulin 30/70) or a premixed analog (e.g. Novomix 30/70). Not mentioning the species of insulin is another error that physicians often make.

Considering the various issues involved, it would be advisable for the physicians to write the prescription in full form mentioning the trade name, generic name as well as the species and also expect the manufacturers to agree upon a common formula to designate insulin and analogs depending upon the species, type of insulin and combinations involved. It is heartening to note that steps are being taken in this direction by adding a suffix like R or N to indicate the type of insulin.

 :: References Top

1.Patel V, Vaidya R, Naik D, Borker P. Irrational drug use in India: A prescription survey from Goa. J Postgrad Med 2005;51:9-12  Back to cited text no. 1    
2.Rataboli PV, Garg A. Confusing brand names: Nightmare of medical profession. J Postgrad Med 2005;51:13-6.   Back to cited text no. 2    
3.Mehta S, Gogtay NJ. From the pen to the patient: Minimising medication errors. J Postgrad Med 2005;51:3-4  Back to cited text no. 3    
4.Adlersberg MA, Fernando S, Spollett GR, Inzucchi SE. Glargine and lispro: two cases of mistaken identity. Diabetes Care 2002;25:404-5.  Back to cited text no. 4    
5.White JR. How can pharmacists help avoid medication errors in the use of insulin Glargine (Lantus)? [Monograph on the Internet] US Pharmacist (cited 2005 May 31) Available from show=article&page=8_1079.htm  Back to cited text no. 5    

This article has been cited by
1 A survey of percutaneous endoscopic gastrostomy in 202 Japanese medical institutions
Suzuki, Y., Urashima, M., Ninomiya, H., Sowa, M., Hiki, Y., Suzuki, H., Ishibashi, Y., (...), Yanaga, K.
Japan Medical Association Journal. 2006; 49(3): 94-105


Print this article  Email this article
Previous article Next article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow